Ajax-Loading

Eli Lilly and Company - Total Long Term Debt

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The indicator "Total-Long-Term-Debt" stands at 15.35 Billion United States Dollars as of 12/31/2021, the highest value at least since 03/31/2011, the period currently displayed. Regarding the Three-Year-Change of the series, the current value constitutes an increase of 127.68 percent compared to the value three years prior.
The 3 year change in percent is 127.68.
The 5 year change in percent is 146.74.

The Serie's long term average value is 12.63 Billion United States Dollars. It's latest available value, on 03/31/2025, is 173.06 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2013, to it's latest available value, on 03/31/2025, is +678.49%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 03/31/2025, is 0.0%.

Total Long Term Debt for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Total Long Term Debt486,508,953,600.00
LogoAbbVie Inc - Total Long Term Debt399,570,305,024.00
LogoRoche Holding AG - Total Long Term Debt317,433,206,677.55
LogoAstraZeneca PLC - Total Long Term Debt280,205,508,085.11
LogoNovartis AG - Total Long Term Debt255,096,620,580.91